On February 19, the AI biology model Evo 2, developed by researchers from the U.S. Arc Institute, chip manufacturer NVIDIA, Stanford University, and other institutions, was officially released.

Circular RNA (circRNA) has emerged as a very attractive alternative to linear mRNA, and several startups, both domestic and international, are already promoting circRNA-based RNA therapeutics.